Gaudium IVF and Women Health Limited IPO: Issue Price, Listing Gain and Share Price Now
Gaudium IVF and Women Health Limited listed on 27-Feb-2026 at ₹80.48 against an issue price of ₹79 , a listing gain of +1.87%. It last traded at ₹113.63 (25-Aug-2026). This page is the record of that issue and what has happened to it since — reported figures only.
Gaudium IVF and Women Health Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹79 |
| Listing price (listing-day close) | ₹80.48 |
| Listing gain | +1.87% |
| Price now | ₹113.63 |
| Change from issue price | +43.84% |
| Change from listing-day close | +41.19% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Gaudium IVF and Women Health Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹79 |
| Issue size | ₹165 Cr |
| Fresh issue | ₹90 Cr |
| Offer for sale | ₹75 Cr |
| Issue opened | 20-Feb-2026 |
| Issue closed | 24-Feb-2026 |
| Listed on | 27-Feb-2026 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Sarthi Capital Advisors (left lead) |
How the Gaudium IVF and Women Health Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 1.62x |
| NII | 14.05x |
| Retail | 7.60x |
| Total | 7.27x |
Gaudium IVF and Women Health Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹827 Cr |
| Trailing P/E | 35.70x |
| Return on capital employed | 29.3% |
| Return on equity | 24.7% |
| 52-week high | ₹164 |
| 52-week low | ₹69.2 |
| Sector | Healthcare Service Provider |
Fundamentals are as of the desk's last harvest and move with the market.
- Gaudium IVF and Women Health Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.